[MODIFICATIONS OF THE EEG DUE TO PSYCHOPHARMACOLOGICAL TREATMENT. LONG-TERM STUDIES ON MENTAL PATIENTS].
D001534:Bemegride; D002719:Chlormethiazole; D002746:Chlorpromazine; D004569:Electroencephalography; D006220:Haloperidol; D006801:Humans; D006993:Hypnotics and Sedatives; D007099:Imipramine; D001523:Mental Disorders; D028642:Persons with Psychiatric Disorders; D008620:Meprobamate; D008728:Methotrimeprazine; D009966:Orphenadrine; D010640:Phenothiazines; D011346:Prochlorperazine; D011600:Psychopharmacology; D013566:Sympathomimetics; D014291:Trimeprazine
D006993:Hypnotics and Sedatives; D010640:Phenothiazines; D013566:Sympathomimetics; D002719:Chlormethiazole; D001534:Bemegride; D014291:Trimeprazine; D008728:Methotrimeprazine; D008620:Meprobamate; D009966:Orphenadrine; D006220:Haloperidol; D007099:Imipramine; D002746:Chlorpromazine; D011346:Prochlorperazine; C084825:thioproperazine
BEMEGRIDE; CHLORMETHIAZOLE; CHLORPROMAZINE; ELECTROENCEPHALOGRAPHY; HALOPERIDOL; HYPNOTICS AND SEDATIVES; IMIPRAMINE; MENTAL DISORDERS; MEPROBAMATE; METHOTRIMEPRAZINE; ORPHENADRINE; PROCHLORPERAZINE; PSYCHOPHARMACOLOGY; SYMPATHOMIMETICS; THIOPROPERAZINE; TRIMEPRAZINE
DIE MODIFIKATIONEN DES EEG UNTER DER BEHANDLUNG MIT PSYCHOPHARMAKA. LANGZEITUNTERSUCHUNGEN AN GEISTESKRANKEN.